Abstract

BackgroundResistance-nodulation-division (RND) efflux pumps are important mediators of antibiotic resistance. RND pumps, including the principal multidrug efflux pump AcrAB-TolC in Salmonella, are tripartite systems with an inner membrane RND transporter, a periplasmic adaptor protein (PAP) and an outer membrane factor (OMF). We previously identified the residues required for binding between the PAP AcrA and the RND transporter AcrB and have demonstrated that PAPs can function with non-cognate transporters. AcrE and AcrD/AcrF are homologues of AcrA and AcrB, respectively. Here, we show that AcrE can interact with AcrD, which does not possess its own PAP, and establish that the residues previously identified in AcrB binding are also involved in AcrD binding. MethodsThe acrD and acrE genes were expressed in a strain lacking acrABDEF (Δ3RND). PAP residues involved in promiscuous interactions were predicted based on previously defined PAP-RND interactions and corresponding mutations generated in acrA and acrE. Antimicrobial susceptibility of the mutant strains was determined.ResultsCo-expression of acrD and acrE significantly decreased susceptibility of the Δ3RND strain to AcrD substrates, showing that AcrE can form a functional complex with AcrD. The substrate profile of Salmonella AcrD differed from that of Escherichia coli AcrD. Mutations targeting the previously defined PAP-RND interaction sites in AcrA/AcrE impaired efflux of AcrD-dependent substrates.ConclusionsThese data indicate that AcrE forms an efflux-competent pump with AcrD and thus presents an alternative PAP for this pump. Mutagenesis of the conserved RND binding sites validates the interchangeability of AcrA and AcrE, highlighting them as potential drug targets for efflux inhibition.

Highlights

  • These data indicate that AcrE forms an efflux-competent pump with AcrD and presents an alternative periplasmic adaptor protein (PAP) for this pump

  • Mutagenesis of the conserved RND binding sites validates the interchangeability of AcrA and AcrE, highlighting them as potential drug targets for efflux inhibition

  • Tripartite RND pumps span the double membrane of Gram-negative bacteria and consist of an inner membrane RND transporter, a periplasmic adaptor protein (PAP) and an outer membrane factor (OMF).[7,8,9]

Read more

Summary

Introduction

MDR efflux pumps play a major role in antibiotic resistance of bacteria by reducing the intracellular concentration of drugs.[1,2] The resistance-nodulation-division (RND) family of efflux pumps confer clinically relevant antibiotic resistance on Gram-negative bacteria, such as Salmonella enterica.[3,4,5,6] Tripartite RND pumps span the double membrane of Gram-negative bacteria and consist of an inner membrane RND transporter, a periplasmic adaptor protein (PAP) and an outer membrane factor (OMF).[7,8,9] The majority of RND pumps exhibit a broad substrate profile, which includes multiple classes of antibiotics, biocides, detergents, dyes and metals.[10,11,12]S. enterica has five RND pumps: AcrAB, AcrD, AcrEF, MdtABC and MdsABC.[5]. MDR efflux pumps play a major role in antibiotic resistance of bacteria by reducing the intracellular concentration of drugs.[1,2] The resistance-nodulation-division (RND) family of efflux pumps confer clinically relevant antibiotic resistance on Gram-negative bacteria, such as Salmonella enterica.[3,4,5,6] Tripartite RND pumps span the double membrane of Gram-negative bacteria and consist of an inner membrane RND transporter, a periplasmic adaptor protein (PAP) and an outer membrane factor (OMF).[7,8,9] The majority of RND pumps exhibit a broad substrate profile, which includes multiple classes of antibiotics, biocides, detergents, dyes and metals.[10,11,12]. We show that AcrE can interact with AcrD, which does not possess its own PAP, and establish that the residues previously identified in AcrB binding are involved in AcrD binding

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call